EM 5854Alternative Names: EM5854
Latest Information Update: 06 Jan 2016
At a glance
- Originator Endoceutics
- Class Steroids
- Mechanism of Action Androgen receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I/II Prostate cancer
Most Recent Events
- 06 Jan 2016 Phase-I/II development for Prostate cancer is ongoing in Canada